CVS’s Beaten-Down Stock Gains After It Boosts Outlook
(Bloomberg) -- CVS Health Corp. boosted its profit outlook after posting stronger-than-expected first-quarter results, an encouraging sign for the health giant after it earlier signaled that 2019 could be a tough year.
- The company now expects adjusted earnings per share this year of $6.75 to $6.90, higher than the $6.68 to $6.88 that it had earlier forecast.
Key Insights
- CVS had warned in February of a transition year, as results would likely be hit by rising costs and poor results from a nursing-home pharmacy unit. The performance of some units in the first quarter was helped by the addition of recently acquired Aetna.
- Political pressure on pharmacy-benefit managers has been growing as Washington looks to rein in drug prices. CVS's Caremark is one of the biggest PBMs, and along with rivals it faces a probe by several states of its business practices.
- The drugstore business has been squeezed by competitive pressure from online retailers and political wrangling over prescription costs, though CVS's sales in the quarter were better than forecast. Last month, Walgreens warned its profits would be flat this year, hitting that company's stock hard.
Market Reaction
CVS shares rose 3.5 percent to $56.29 at 9:34 a.m. in New York on Wednesday. Through Tuesday's close, the stock had fallen 17 percent this year amid a widespread decline in shares of insurers and other health-care companies.
Get More
- Read more details on CVS's results here.
- View the company's full news release here.
To contact the reporter on this story: Robert Langreth in New York at rlangreth@bloomberg.net
To contact the editors responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net, Timothy Annett
©2019 Bloomberg L.P.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
